Our mission is to improve human health and society by understanding and applying the power of biology to develop breakthrough research technologies and diagnostic products.
Applera Corporation consists of two business groups -- the Applied Biosystems group and the Celera Genomics group.
The Applied Biosystems Group (NYSE: ABI) serves the life science industry and research community by developing and marketing instrument-based systems, consumables, software, and services. Customers use these tools to analyze nucleic acids (DNA and RNA), small molecules, and proteins to make scientific discoveries and develop new pharmaceuticals. Applied Biosystems’ products also serve the needs of some markets outside of life science research, which we refer to as “applied markets,” such as the fields of: human identity testing (forensic and paternity testing); biosecurity, which refers to products needed in response to the threat of biological terrorism and other malicious, accidental, and natural biological dangers; and quality and safety testing, for example in food and the environment.
The Celera Genomics Group uses proprietary genomics and proteomics discovery platforms to develop molecular diagnostic products and to identify and validate novel drug targets. Celera maintains a strategic alliance in molecular diagnostics with Abbott. In addition, Celera is developing new molecular diagnostic and pharmacogenomic assays outside of its alliance with Abbott. Therapeutic antibodies against Celera-discovered drug targets are being advanced through strategic partnerships.
| Contact Details: |
| 301 Merritt 7P.O. Box 5435 |
| Norwalk |
| Connecticut |
| 06856-5435 |
| United States of America |
| Tel: | 1 203-840-2000,1 800-761-5381 |
| Fax: | 1 650-638-5884 |
| Email: | |
| WWW: | www.applera.com/
|
|
Loading...
|
Recent Publications by Applera Corporation: |  |
Setting up a 2D-LC/MS/MS method for the rapid quantitation of the prostanoid metabolites 6-oxo-PGF(1alpha) and TXB2 as markers for hemostasis assessment.
6-oxo-PGF(1alpha) and TXB(2) are the metabolites of the prostanglandin... | 19th August, 2009
| Applied Biosystems, Applera Italia, Monza, Italy.
| J Mass Spectrom. 2009 Mar;44(3):346-52.
DOI Direct Link |
Detection of protein-RNA crosslinks by NanoLC-ESI-MS/MS using precursor ion scanning and multiple reaction monitoring (MRM) experiments.
Protein-RNA interactions within ribonucleoprotein particles (RNPs) can be... | 6th June, 2007
| Applera Deutschland GmbH, Darmstadt, Germany.
| J Am Soc Mass Spectrom. 2007 May;18(5):869-81. Epub 2007 Mar 8.
DOI Direct Link |
Rapid amplification of cDNA ends.
Protein-RNA interactions within ribonucleoprotein particles (RNPs) can be... | 3rd December, 2003
| CELERA, an Applera Corporation Business, Rockville, MD, USA.
| Methods Mol Biol. 2003;226:105-16.
DOI Direct Link |
Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 446 times since April 2007, the link to the organisation's website has been followed 73 times
Recent Search Terms used to find this page: applera rockville md | Applera Corporation | Applera Corporation | applera corporation | .
Search for more companies in Norwalk
Search for more companies in Connecticut
This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for
Applera Corporation
